.sanofi

From ICANNWiki
Jump to: navigation, search
Status: Delegated
Registry Provider: Verisign
Registry: Sanofi
Registry Backend: Verisign
Type: Brand TLD
Priority #: 780 - Sanofi
nTLDStats
Registrations: 7
Parked Domains: 7
Parked Domain %: 100.0 %
Important Dates
Delegation: 24 July 2015
General Availability: N/A

More Information: NTLDStatsLogo.png

.sanofi is a Brand TLD delegated in ICANN's New gTLD Program. Sanofi manages the TLD and is its Registry. The proposed application succeeded and was delegated to the Root Zone on 24 July, 2015.[1].[2]

Application Details

The following is excerpted from the applicant's response to question #18:

"The .sanofi gTLD will create a new generation gTLD serving the interests of end users by providing an authoritative Internet space where information, services and resources of Sanofi, and its affiliates, will be closely controlled by Sanofi. The majority of the anticipated domain name registrations in the .sanofi gTLD will be used in the promotion and communication of the Sanofi brand and other related services. A subset of domain names has the potential to be created and used for communication and marketing purposes, with internet users assured of brand authenticity.

As the new .sanofi gTLD expands and evolves, Sanofi may consider allowing its distribution network and other parties associated with the distribution of Sanofi products and solutions, or otherwise associated with the Sanofi brand and range of products and services, to register second-level domains at a later date.

Sanofi is a global and diversified healthcare leader, which discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in healthcare, with 6 growth platforms: emerging markets, vaccines, consumer healthcare, diabetes treatments, innovative products and animal health. Through the acquisition of Genzyme, Sanofi has strongly reinforced its footprint in rare diseases. Sanofi works to protect the health of the earth’s 7 billion inhabitants, improve their quality of life and respond to their potential needs. Sanofi is continually creating new approaches to its activities and work sectors, and are mobilized for the primary goal of bringing medicines and vaccines to patients. To make tomorrow’s therapeutic solutions real, Sanofi seeks to innovate with its partners, who, like Sanofi, aim for excellence and efficiency."[3]

References